The US economy may be contracting sharply in some industries, but drug makers spent $2b more on research in 2008 [MORE]
Abbott’s i-STAT handheld blood analyzer has just received an FDA waiver for five more tests using its 18 cartridges, which [MORE]
Genetic Engineering & Biotechnology News reported recently that GSK’s deal with Actelion, worth almost $3.2 billion, for Actelion’s insomnia drug [MORE]